NAS:GMDA (Israel)  
Gamida Cell Ltd logo

Gamida Cell Ltd

$ 1.55 -0.01 (-0.64%) 08:08 PM EST
P/E:
At Loss
P/B:
8.61
Market Cap:
$ 115.29M
Enterprise V:
$ 132.79M
Volume:
244.19K
Avg Vol (2M):
494.59K
Volume:
244.19K
Market Cap $:
115.29M
PE Ratio:
At Loss
Avg Vol (2-Month):
494.59K
Enterprise Value $:
132.79M
PB Ratio:
8.61
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Gamida Cell Ltd is a biopharmaceutical company involved in developing advanced cell therapies with the potential to cure cancer and rare, serious hematologic diseases. The company's product includes NiCord that is a cell therapy based on NAM-expanded cord blood designed to enhance and expand the life-saving benefits of hematopoietic stem cell transplant. It is also developing GDA-201 which is innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma. It is developing a diverse pipeline of cell therapies using its proprietary NAM technology that has the potential to bring life-saving treatment options to patients.
Name Current Vs Industry Vs History
Cash-To-Debt 0.79
Equity-to-Asset 0.12
Debt-to-Equity 5.76
Debt-to-EBITDA -1.01
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.05
9-Day RSI 39.85
14-Day RSI 41.15
6-1 Month Momentum % -22.07
12-1 Month Momentum % -28.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.76
Quick Ratio 2.76
Cash Ratio 2.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34
Name Current Vs Industry Vs History
ROE % -295.17
ROA % -60.88
ROIC % -151.29
ROC (Joel Greenblatt) % -184.29
ROCE % -71.21

Financials (Next Earnings Date:2023-03-15 Est.)

GMDA's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:GMDA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.35
Beta 1.61
Volatility % 98.64
14-Day RSI 41.15
14-Day ATR ($) 0.150996
20-Day SMA ($) 1.729
12-1 Month Momentum % -28.22
52-Week Range ($) 1.32 - 4.72
Shares Outstanding (Mil) 74.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gamida Cell Ltd Filings

Document Form Filing Date
No Filing Data

Gamida Cell Ltd Analysis

Share your research

Headlines

See More
No news.